NCT00004409 2015-03-25
Phase II Randomized Study of Collagenase in Patients With Residual Type Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 2 Completed
Clinical Trials
8 trialsNCT00004424 2015-03-25
Randomized Study of Propofol Versus Fentanyl and Midazolam in Pediatric Patients Requiring Mechanical Ventilation and Sedation Therapy
FDA Office of Orphan Products Development
Phase NA Completed
NCT00004436 2015-03-25
Randomized Study of Hormonal Regulation of Infantile Hemangioma
FDA Office of Orphan Products Development
Phase NA Completed
NCT00004437 2015-03-25
Phase II Study of the Multichannel Auditory Brain Stem Implant for Deafness Following Surgery for Neurofibromatosis 2
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00004688 2015-03-25
Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms
FDA Office of Orphan Products Development
Phase 2 Completed
NCT00004832 2015-03-25
Randomized Study of 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome
FDA Office of Orphan Products Development
Phase NA Completed
NCT00004941 2015-03-25
Phase III Randomized Study of Anti-Tumor Necrosis Factor Chimeric Monoclonal Antibody (cA2) for Patients With Enterocutaneous Fistulae as a Complication of Crohn's Disease
FDA Office of Orphan Products Development
Phase 3 Completed
NCT00014742 2015-03-25
Phase III Randomized Study of Collagenase in Patients With Residual Stage Dupuytren's Disease
FDA Office of Orphan Products Development
Phase 3 Completed